Home » Newsletters » BioWorld Science

BioWorld Science

March 24, 2020

View Archived Issues

Sorrento develops Covidtrap protein for potential prevention and treatment COVID-19

BET on BD1 for cancer, BD2 for inflammation

Recruiting NK cells to the antitumor battle

AnHeart receives clinical trial authorization for taletrectinib in China

European Commission approves intravenous formulation of Akynzeo

FDA approves phase III study of Actemra in patients with severe COVID-19 pneumonia

First-in-human study of PLN-1474 for the treatment of liver fibrosis

Phase I data for influenza vaccination with a high-density microarray patch

Phase II data presented for intratumoral tavokinogene telseplasmid in metastatic melanoma

Researchers identify lncRNA RPL34-AS1 as potential therapeutic target in esophageal cancer

Arena Pharmaceuticals patents S1P1 agonists

Antibody gene therapy with AAV8-VRC07 appears feasible in HIV patients

Birdie Biopharmaceuticals discloses new imidazoquinoline derivatives

Pipeline Therapeutics identifies muscarinic M1 receptor antagonists

Achillion Pharmaceuticals presents complement factor D inhibitors

New eiF4E inhibitors presented by Pic Therapeutics

Biomedical R&D takes hit as university labs, trials shut down due to COVID-19

New MAb increases the effects of PF4 in sepsis, stabilizing NETs and enhancing microbial entrapment

AveXis releases new data from phase I/II study of intrathecal AVXS-101 in SMA type 2

Milestone reports phase III topline data on at-home use of etripamil for PSVT

Ascentage doses first U.S. patient in global study of APG-2575 for relapsed/refractory CLL/SLL

Synthon studies ADC SYD-1875 in first-in-human study for locally advanced or metastatic cancer

14,15-DHET is a marker of doxorubicin-related cardiotoxicity

USP28 regulates deltaNp63 protein abundance in squamous cell carcinoma and can be a druggable target

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...